Clal Biotechnology Industries Ltd Capital Reinvestment Ratio

Latest as of September 2020: 0.73x

Clal Biotechnology Industries Ltd capital reinvestment ratio. Clal Biotechnology Industries Ltd (CBI) has a Capital Reinvestment Ratio of 0.73x as of September 2020, meaning it reinvests 1% of its operating cash flow (ILA1.10 Million) in capital expenditures (ILA806.00K). Check CBI cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.73x

Capex / Operating Cash Flow

Operating Cash Flow

ILA1.10 Million

ILA

Capital Expenditures

ILA806.00K

ILA

Data as of

Sep 2020

Most recent filing

Capital Reinvestment Ratio of Clal Biotechnology Industries Ltd (2019–2019)

Capital reinvestment ratio of Clal Biotechnology Industries Ltd from 2019 to 2019. This chart tracks Clal Biotechnology Industries Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore net asset momentum of Clal Biotechnology Industries Ltd to track the company's year-over-year net asset growth rate.

Clal Biotechnology Industries Ltd Capital Reinvestment Ratio by Year (2019–2019)

Clal Biotechnology Industries Ltd capital reinvestment ratio by year from 2019 to 2019. For the full cash flow conversion analysis, see CBI operating cash flow.

Year	Reinvestment Ratio	Operating CF (ILA)	Capital Expenditures	YoY Change
2019	0.10x	ILA27.03 Million	ILA2.83 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow